EcoR1 Capital’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-3,341,653
| Closed | -$11.2M | – | 46 |
|
2024
Q4 | $11.2M | Sell |
3,341,653
-2,100,243
| -39% | -$7.04M | 0.42% | 36 |
|
2024
Q3 | $18.2M | Hold |
5,441,896
| – | – | 0.62% | 35 |
|
2024
Q2 | $18M | Sell |
5,441,896
-703,965
| -11% | -$2.33M | 0.55% | 37 |
|
2024
Q1 | $24.8M | Sell |
6,145,861
-850,000
| -12% | -$3.43M | 0.63% | 30 |
|
2023
Q4 | $21.3M | Hold |
6,995,861
| – | – | 0.55% | 30 |
|
2023
Q3 | $21M | Hold |
6,995,861
| – | – | 0.71% | 26 |
|
2023
Q2 | $26.2M | Buy |
6,995,861
+811,000
| +13% | +$3.03M | 0.64% | 21 |
|
2023
Q1 | $20.7M | Hold |
6,184,861
| – | – | 0.67% | 27 |
|
2022
Q4 | $29.7M | Hold |
6,184,861
| – | – | 0.91% | 21 |
|
2022
Q3 | $35.2M | Sell |
6,184,861
-155,778
| -2% | -$886K | 1.04% | 22 |
|
2022
Q2 | $45M | Hold |
6,340,639
| – | – | 1.55% | 20 |
|
2022
Q1 | $45.8M | Buy |
6,340,639
+964,505
| +18% | +$6.96M | 1.43% | 20 |
|
2021
Q4 | $48.1M | Buy |
+5,376,134
| New | +$48.1M | 1.53% | 20 |
|